DCEMRI of spontaneous canine tumors during fractionated radiotherapy: A pharmacokinetic analysis

Radiotherapy and Oncology

Volumn 93, Issue 3, 2009, Pages 618-624

  Søvik, Åste ^a,b   Skogmo, Hege Kippenes ^b   Andersen, Erlend K F ^a,c   Bruland, Øyvind S ^a,b,c   Olsen, Dag Rune ^a,c   Malinen, Eirik ^a  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b NORWEGIAN UNIVERSITY OF LIFE SCIENCES   (Norway)

^c UNIVERSITY OF OSLO   (Norway)

Author keywords

DCEMRI; Pharmacokinetic analysis; Radiotherapy; Treatment response

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER RADIOTHERAPY; DOG; DYNAMIC CONTRAST ENHANCED MAGNETIC RESONANCE IMAGING; MOUTH TUMOR; NONHUMAN; NOSE TUMOR; NUCLEAR MAGNETIC RESONANCE IMAGING; PARAMETER; PRIORITY JOURNAL; RADIATION DOSE; TREATMENT RESPONSE;

ANIMALS; CONTRAST MEDIA; DOG DISEASES; DOGS; DOSE FRACTIONATION; GADOLINIUM DTPA; MAGNETIC RESONANCE IMAGING; MOUTH NEOPLASMS; NOSE NEOPLASMS; RADIOTHERAPY DOSAGE; RADIOTHERAPY, CONFORMAL;

EID: 70449646961     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.radonc.2009.08.012     Document Type: Article

References (23)

1. Chapman J.D., Bradley J.D., Eary J.F., et al. Molecular (functional) imaging for radiotherapy applications: an RTOG symposium. Int J Radiat Oncol Biol Phys 55 (2003) 294-301
2. Rajendran J.G., and Mankoff D.A. Beyond detection: novel applications for PET imaging to guide cancer therapy. J Nucl Med 48 (2007) 855-856
3. Padhani A.R. Dynamic contrast-enhanced MRI in clinical oncology: current status and future directions. J Magn Reson Imaging 16 (2002) 407-422
4. Weber W.A. PET for response assessment in oncology: radiotherapy and chemotherapy. Br J Radiol S28 (2005) 42-47
5. Sovik A., Malinen E., Skogmo H.K., Bentzen S.M., Bruland O.S., and Olsen D.R. Radiotherapy adapted to spatial and temporal variability in tumor hypoxia. Int J Radiat Oncol Biol Phys 68 (2007) 1496-1504
6. Zahra M.A., Hollingsworth K.G., Sala E., Lomas D.J., and Tan L.T. Dynamic contrast-enhanced MRI as a predictor of tumour response to radiotherapy. Lancet Oncol 8 (2007) 63-74
7. Choyke P.L., Dwyer A.J., and Knopp M.V. Functional tumor imaging with dynamic contrast-enhanced magnetic resonance imaging. J Magn Reson Imaging 17 (2003) 509-520
8. Jackson A., O'Connor J.P., Parker G.J., and Jayson G.C. Imaging tumor vascular heterogeneity and angiogenesis using dynamic contrast-enhanced magnetic resonance imaging. Clin Cancer Res 13 (2007) 3449-3459
9. Larsson H.B., Stubgaard M., Frederiksen J.L., Jensen M., Henriksen O., and Paulson O.B. Quantitation of blood-brain barrier defect by magnetic resonance imaging and gadolinium-DTPA in patients with multiple sclerosis and brain tumors. Magn Reson Med 16 (1990) 117-131
10. Brix G., Semmler W., Port R., Schad L.R., Layer G., and Lorenz W.J. Pharmacokinetic parameters in CNS Gd-DTPA enhanced MR imaging. J Comput Assist Tomogr 15 (1991) 621-628
11. Tofts P.S., and Kermode A.G. Measurement of the blood-brain barrier permeability and leakage space using dynamic MR imaging. 1. Fundamental concepts. Magn Reson Med 17 (1991) 357-367
12. Sovik A., Kippenes S.H., Bruland O.S., Rune O.D., and Malinen E. DCEMRI monitoring of canine tumors during fractionated radiotherapy. Acta Oncol 47 (2008) 1249-1256
13. Tofts P.S. Modeling tracer kinetics in dynamic Gd-DTPA MR imaging. J Magn Reson Imaging 7 (1997) 91-101
14. Tofts P.S., Brix G., Buckley D.L., et al. Estimating kinetic parameters from dynamic contrast-enhanced T(1)-weighted MRI of a diffusable tracer: standardized quantities and symbols. J Magn Reson Imaging 10 (1999) 223-232
15. Port R.E., Knopp M.V., Hoffmann U., Milker-Zabel S., and Brix G. Multicompartment analysis of gadolinium chelate kinetics: blood-tissue exchange in mammary tumors as monitored by dynamic MR imaging. J Magn Reson Imaging 10 (1999) 233-241
16. van Osch M.J., Vonken E.J., Viergever M.A., van der G.J., and Bakker C.J. Measuring the arterial input function with gradient echo sequences. Magn Reson Med 49 (2003) 1067-1076
17. Hawighorst H., Weikel W., Knapstein P.G., et al. Angiogenic activity of cervical carcinoma: assessment by functional magnetic resonance imaging-based parameters and a histomorphological approach in correlation with disease outcome. Clin Cancer Res 4 (1998) 2305-2312
18. Loncaster J.A., Carrington B.M., Sykes J.R., et al. Prediction of radiotherapy outcome using dynamic contrast enhanced MRI of carcinoma of the cervix. Int J Radiat Oncol Biol Phys 54 (2002) 759-767
19. Zahra M.A., Tan L.T., Priest A.N., et al. Semiquantitative and quantitative dynamic contrast-enhanced magnetic resonance imaging measurements predict radiation response in cervix cancer. Int J Radiat Oncol Biol Phys 74 (2009) 766-773
20. Hawighorst H., Engenhart R., Knopp M.V., et al. Intracranial meningiomas: time- and dose-dependent effects of irradiation on tumor microcirculation monitored by dynamic MR imaging. Magn Reson Imaging 15 (1997) 423-432
21. Oberholzer K., Pohlmann A., Schreiber W., et al. Assessment of tumor microcirculation with dynamic contrast-enhanced MRI in patients with esophageal cancer: initial experience. J Magn Reson Imaging 27 (2008) 1296-1301
22. Rose C.J., Mills S., O'Connor J.P., et al. Quantifying heterogeneity in dynamic contrast-enhanced MRI parameter maps. Med Image Comput Comput Assist Interv Int Conf Med Image Comput Comput Assist Interv. 10 (2007) 376-384
23. Devries A.F., Griebel J., Kremser C., et al. Tumor microcirculation evaluated by dynamic magnetic resonance imaging predicts therapy outcome for primary rectal carcinoma. Cancer Res 61 (2001) 2513-2516